Hugel (145020) stock
KOSDAQ · Biotechnology
As of the Nov 16 regular-session close (Korea)
Events and reference metrics · 1
- Market cap
- KRW 2.4 trillion
- As of Nov 16, 2026
- P/E
- 19.34x
- Trailing twelve months
- P/B
- 2.40x
- Latest reported equity
- P/S
- 5.11x
- Trailing twelve months
- ROE
- 12.4%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
- Market cap
- KRW 2.4 trillion
- As of Nov 16, 2026
- P/E
- 19.34x
- Trailing twelve months
- P/B
- 2.40x
- Latest reported equity
- P/S
- 5.11x
- Trailing twelve months
- ROE
- 12.4%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
19.34x
P/B
2.40x
P/S
5.11x
Earnings and dividend metrics▾
Earnings
EPS
KRW 9,950
Earnings per share
BPS
KRW 80,177
Book value per share
ROE
12.4%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned KRW 9,950 per share.
- BPS — net assets divided by the number of shares. Each share is backed by KRW 80,177 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 12.4%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from DART financial filings: net income attributable to owners of the parent and revenue are summed over the latest four quarters, equity is the latest reported equity, and prices are KRX closing prices.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Earnings
Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| Q2 2026Consolidated · Filed Aug 14, 2026 | KRW 137.9 billion | KRW 56 billion | KRW 44.7 billion | +25.1% |
| Q1 2026Consolidated · Filed May 15, 2026 | KRW 116.6 billion | KRW 47.6 billion | KRW 40.6 billion | +29.9% |
| Q4 2025Consolidated · Filed Mar 20, 2026 | KRW 119.1 billion | KRW 57.8 billion | KRW 39.8 billion | — |
| Q3 2025Consolidated · Filed Nov 14, 2025 | KRW 105.9 billion | KRW 47.4 billion | KRW 38 billion | +0.8% |
| Q2 2025Consolidated · Filed Aug 14, 2025 | KRW 110.3 billion | KRW 56.7 billion | KRW 38.2 billion | +15.5% |
| Q1 2025Consolidated · Filed May 15, 2025 | KRW 89.8 billion | KRW 39 billion | KRW 30.9 billion | +20.9% |
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| FY2025Consolidated · Filed Mar 20, 2026 | KRW 425.1 billion | KRW 200.9 billion | KRW 147 billion | — |
| FY2024Consolidated · Filed Mar 21, 2025 | KRW 373 billion | KRW 166.2 billion | KRW 143.1 billion | — |
- Q2 2026 is computed as H1 2026 minus Q1 2026.
- Q4 2025 is computed as FY2025 minus 9M 2025.
- Q3 2025 is computed as 9M 2025 minus H1 2025.
- Q2 2025 is computed as H1 2025 minus Q1 2025.
Short selling and securities lending
Short sales as a share of trading value, the reported short position and the securities lending balance.
- Short-sale share
- 21.40%
- Of trading value on Nov 13, 2026
- Short-sale value
- KRW 2.01 billion
- Previous 20-day average 16.07%
- Net short position
- 12,755 shares
- As of Nov 11, 2026 · reported with a two-trading-day lag
- Lending balance
- 437,262 shares
- As of Nov 13, 2026 · 3.49% of listed shares
| Date | Share | Value |
|---|---|---|
| Nov 13, 2026 | 21.40% | KRW 2.01 billion |
| Nov 12, 2026 | 22.08% | KRW 2.82 billion |
| Nov 11, 2026 | 16.13% | KRW 1.98 billion |
| Nov 10, 2026 | 7.48% | KRW 1.15 billion |
| Nov 9, 2026 | 13.15% | KRW 1.25 billion |
| Nov 6, 2026 | 5.00% | KRW 1.12 billion |
| Nov 5, 2026 | 5.44% | KRW 1.04 billion |
| Nov 4, 2026 | 20.24% | KRW 5.1 billion |
| Nov 3, 2026 | 18.86% | KRW 2.58 billion |
| Nov 2, 2026 | 15.42% | KRW 970 million |
The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.
Filings
Major filings received by DART, Korea’s regulatory filing system.
- Decision on Share Cancellation(Korean)Nov 4, 2026 · Share Cancellation
- Preliminary Consolidated Operating Results (Fair Disclosure)Nov 4, 2026 · Preliminary EarningsEnglish
- Stock Option GrantNov 4, 2026English
- Report on Specified Securities Held by Executives and Major ShareholdersSep 30, 2026 · Insider Ownership ReportEnglish
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Sep 9, 2026 · Insider Ownership Report
- [Amended] Results of Extraordinary General Meeting(Korean)Aug 24, 2026 · Shareholders Meeting
- Results of Extraordinary General Meeting(Korean)Aug 21, 2026 · Shareholders Meeting
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Aug 21, 2026 · Insider Ownership Report
Filings with a published English version open in English; the rest link to the Korean original.
Hugel (145020) stock information
KOSDAQ
Hugel (145020) is listed on KOSDAQ. Its market capitalization is about KRW 2.4 trillion. On trailing-twelve-month earnings the P/E ratio is 19.34, and the P/B ratio is 2.4. Return on equity is 12.4%. These figures are computed in-house from official filings and are reference information only.
Hugel — frequently asked questions
- What is the P/E ratio of Hugel (145020)?
- On a trailing-twelve-month basis, 145020 trades at a P/E ratio of 19.34. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Hugel?
- 145020 has a market capitalization of about KRW 2.4 trillion. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.